TIDMIRIS
RNS Number : 6063N
DCG IRIS Limited
10 September 2013
This announcement is an advertisement and not a prospectus and
investors should not subscribe for or purchase any shares referred
to in this announcement except on the basis of information in the
prospectus published by DCG IRIS Limited on 12 November 2012 and
the supplementary prospectuses dated 13 December 2012, 30 January
2013 and 10 September 2013 in connection with the admission of the
Placing Shares to the Official List of the UK Listing Authority and
the main market of the London Stock Exchange plc. This announcement
is not for release, publication, or distribution, directly or
indirectly, in whole or in part, to US persons or into or within
the United States (including its territories and possessions, any
state of the United States and the District of Columbia),
Australia, Canada, Japan, or any other jurisdiction where to do so
would constitute a violation of the relevant laws or regulations of
such jurisdiction.
DCG IRIS Limited
10 September 2013
Publication of Supplementary Prospectus
DCG IRIS Limited (the "Company") has today published a
supplementary prospectus approved by the UK Listing Authority which
is supplemental to, and should be read in conjunction with, the
Prospectus published by the Company on 12 November 2012 and the
supplementary prospectuses published on 13 December 2012 and 30
January 2013 in relation to the Placing Programme.
Copies of the supplementary prospectus will shortly be available
for inspection at www.hemscott.com/nsm.do and on the Dexion
website: http://dexioncapital.com/dexion-products and, until 11
November 2013, are available for collection from the registered
office of the Company at 3(rd) Floor, 1 Le Truchot, St Peter Port,
Guernsey GY1 1WD and the Company's Placing Agent, Dexion Capital
plc at 1 Tudor Street, London EC4Y 0AH.
Terms used and not defined in this announcement have the
meanings given in the Prospectus.
Dexion Capital plc
Ana Haurie/Robert Peel 020 7832 0900
Dexion Capital (Guernsey) Limited
Gillian Newton/Chris Copperwaite 01481 743 940
Important notices
This announcement does not constitute or form part of, and
should not be construed as, any offer for sale or subscription of,
or solicitation of any offer to buy or subscribe for, any share in
the Company or securities in any other entity, in any jurisdiction,
including the United States, Australia, Canada, Japan, nor shall
it, or any part of it, or the fact of its distribution, form the
basis of, or be relied on in connection with, any contract or
investment decision whatsoever, in any jurisdiction. This
announcement does not constitute a recommendation regarding any
securities.
This announcement is an advertisement and not a prospectus and
investors should not subscribe for or purchase any shares referred
to in this announcement except on the basis of the information in
the prospectus published today by the Company in connection with
the admission of the shares of the Company to the Official List of
the Financial Conduct Authority and to trading on the London Stock
Exchange plc's main market for listed securities (the
"Prospectus"). Copies of the Prospectus are available from the
Company's registered office and as further set out herein.
This announcement, and the information contained therein, is not
for viewing, release, distribution or publication in or into the
United States, Canada, Australia or Japan or any other jurisdiction
where applicable laws prohibit its release, distribution or
publication, and will not be made available to any national,
resident or citizen of the United States, Canada, Australia or
Japan. The distribution of this announcement in other jurisdictions
may be restricted by law and persons into whose possession this
announcement comes must inform themselves about, and observe, any
such restrictions. Any failure to comply with the restrictions may
constitute a violation of the federal securities law of the United
States and the laws of other jurisdictions.
The shares to be issued by the Company (the "Securities") have
not been and will not be registered under the US Securities Act of
1933 (the "Securities Act"), or with any securities regulatory
authority of any state or other jurisdiction of the United States.
The Securities may not be offered, sold, resold, pledged,
delivered, distributed or otherwise transferred, directly or
indirectly, into or within the United States, or to, or for the
account or benefit of, US persons (as defined in Regulation S under
the Securities Act). No public offering of the Securities is being
made in the United States. The Company has not been and will not be
registered under the US Investment Company Act of 1940 (the
"Investment Company Act") and, as such, holders of the Securities
will not be entitled to the benefits of the Investment Company Act.
No offer, sale, resale, pledge, delivery, distribution or transfer
of the Securities may be made except under circumstances that will
not result in the Company being required to register as an
investment company under the Investment Company Act.
All investments are subject to risk, including the loss of the
principal amount invested. Past performance is no guarantee of
future returns. All investments to be held by the Company involve a
substantial degree of risk, including the risk of total loss. You
should always seek expert legal, financial, tax and other
professional advice before making any investment decision.
Neither the Company, Dexion Capital plc, their affiliates nor
any other person (including without limitation, the directors,
officers, employees, partners, agents, representatives, members and
advisers of the Company, Dexion Capital plc and their affiliates)
undertakes any obligation to update or revise any statement made in
this announcement (including, without limitation any forward
looking statements), whether as a result of new information, future
events or otherwise.
The information in this announcement contains forward looking
statements. Any statement other than a statement of historical fact
is a forward looking statement. Actual results may differ
materially from those expressed or implied by any forward looking
statement. You should not place undue reliance on any forward
looking statement, which speaks only as of the date of its
issuance.
This information is provided by RNS
The company news service from the London Stock Exchange
END
PDIDBLBFXKFZBBB
DCG Iris (LSE:IRIS)
Historical Stock Chart
From Jun 2024 to Jul 2024
DCG Iris (LSE:IRIS)
Historical Stock Chart
From Jul 2023 to Jul 2024